of data
support
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
176258-88-1Levothyroxine Acetamide Impurity
● In Stock
| Catalogue No.: | VL1320002 |
|---|---|
| CAS No.: | 176258-88-1 |
| Mol. Formula: | C14H9I4NO3 |
| Mol. Weight: | 746.84 |
Additional information on CAS 176258-88-1
Parent drug
LevothyroxineIUPAC Name
2-(4-(4-Hydroxy-3, 5-diiodophenoxy)-3, 5-diiodophenyl)acetamide.Pharmacopoeial Synonyms
N/AOther Synonyms
Levothyroxine T4-Acetamide; Benzeneacetamide, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-; 3,3′,5,5′-TetraiodothyroacetamideSmile
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(=O)NInChI
InChI=1S/C14H9I4NO3/c15-8-4-7(5-9(16)13(8)21)22-14-10(17)1-6(2-11(14)18)3-12(19)20/h1-2,4-5,21H,3H2,(H2,19,20)Characterization Data (Included)
HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).Additional Characterization Data
QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.Description
Levothyroxine T4-Acetamide, also known as Levothyroxine T4-Acetamide; Benzeneacetamide, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-; 3,3′,5,5′-Tetraiodothyroacetamide is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Levothyroxine. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.
Request a Quote
"*" indicates required fields
